Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a smart car fix your walk? new study tests electric vehicle for Parkinson's and dementia

NCT ID NCT07143006

Symptom relief Sponsor: Taipei Medical University Shuang Ho Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study tested a smart electric vehicle designed to detect and improve walking problems in 120 people aged 60-85 with Parkinson's disease or dementia. The vehicle uses artificial intelligence to monitor gait, provide feedback, and assist with balance. The main goal was to see if it could help patients walk better and more safely.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
BestShape Go Intelligent Generation Transformable Electric Vehicle (a smart electric vehicle device)
What this could lead to
If successful, this could lead to a new way to help people with Parkinson's or dementia walk better and more safely using a smart vehicle.
What could go wrong
This is a small, completed early-stage study. The device may not work for everyone, and results may not apply to all patients with these conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

120 people

The number who actually took part.

Started

Aug 2025

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patients with neurodegenerative diseases(such as Parkinson's disease or dementia). 2. Age: 60-85 years. 3. Capable of walking to some extent, but may have mild to moderate gait disturbances. 4. Able to understand the trial procedures and give informed consent. Exclusion Criteria: 1. Unable to walk or requiring comprehensive physical support. 2. Conditions such as heart disease, uncontrolled high blood pressure, or a history of major surgery. 3. Severe cognitive impairment preventing understanding of the trial procedures or giving informed consent. 4. Visual or auditory impairments severe enough to prevent following trial instructions. 5. Participation in other clinical trials within a certain period in the past, which could affect the assessment of results.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dementia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

dementia neurodegenerative disease Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Dementia Parkinson disease

Contacts and locations

Locations

  • Shuang Ho Hospital

    New Taipei City, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.